Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Gland Surgery|June 16, 2026
Evidence-based perioperative nutritional management for patients undergoing prostate cancer surgery: a systematic reviewYangxing Mao, Tingting Chen, Jing Chen, et al.Chemical Science|February 16, 2026
Few-shot molecular property optimization via a domain-specialized large language modelYan Guo, Menglan Luo, Wenbo Zhang, et al.European Journal of Medicinal Chemistry|June 17, 2022
Design and development of a novel series of oral bivalent BET inhibitors with potent anticancer activitiesMenglan Luo, Qian Wu, Yueyue Yang, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2024
Discovery of a novel series of pyridone amides as NaV1.8 inhibitorsYanfang Wang, Shilong Hu, Yuhao Chen, et al.Bioorganic & Medicinal Chemistry Letters|June 29, 2024
Identification of N-(((1S,3R,5S)-adamantan-1-yl)methyl)-3-((4-chlorophenyl)sulfonyl)benzenesulfonamide as novel Nav1.8 inhibitor with analgesic profileChi Song, Jie Qiu, Menglan Luo, et al.European Journal of Medicinal Chemistry|October 4, 2024
Design and development of a series of 4-(piperazin-1-yl)pyrimidines as irreversible menin inhibitorsMenglan Luo, Yunfei Ye, Lu Tang, et al.Journal of Ethnopharmacology|March 6, 2026
Systems Pharmacology Reveals the Mechanism Underlying Gastrodiae Rhizoma in Improving Stress-Induced Cognitive Impairment: Protecting Hippocampal Synapses from Excessive Microglia-Mediated PruningHaili Zhang, Ling Li, Zhihuang Zhao, et al.Acta Pharmaceutica Sinica. B|July 18, 2022
Discovery of 4-cyclopropyl-3-(2-((1-cyclopropyl-1H-pyrazol-4-yl) amino) quinazolin-6-yl)-N-(3-(trifluoromethyl) phenyl) benzamides as potent discoidin domain receptor inhibitors for the treatment of idiopathic pulmonary fibrosisQi Wang, Bixi Tang, Dandan Sun, et al.Pageof 1